Victory Capital Management Inc. Boosts Stock Holdings in The Clorox Company (NYSE:CLX)

Victory Capital Management Inc. boosted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 3.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 172,526 shares of the company's stock after acquiring an additional 6,510 shares during the quarter. Victory Capital Management Inc. owned approximately 0.14% of Clorox worth $24,600,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. Fortitude Family Office LLC acquired a new stake in shares of Clorox in the fourth quarter worth about $29,000. Tyler Stone Wealth Management raised its position in Clorox by 64.5% in the third quarter. Tyler Stone Wealth Management now owns 255 shares of the company's stock worth $33,000 after purchasing an additional 100 shares in the last quarter. Hartford Financial Management Inc. increased its holdings in Clorox by 57.1% during the fourth quarter. Hartford Financial Management Inc. now owns 256 shares of the company's stock worth $37,000 after buying an additional 93 shares during the last quarter. Valley National Advisers Inc. lifted its position in Clorox by 458.3% during the fourth quarter. Valley National Advisers Inc. now owns 268 shares of the company's stock worth $38,000 after acquiring an additional 220 shares during the last quarter. Finally, BKM Wealth Management LLC bought a new stake in shares of Clorox during the fourth quarter worth approximately $41,000. 78.53% of the stock is owned by institutional investors.

Clorox Price Performance

CLX traded up $1.14 during trading on Thursday, reaching $141.56. The stock had a trading volume of 816,418 shares, compared to its average volume of 1,265,905. The business has a 50-day moving average of $148.00 and a 200-day moving average of $143.67. The Clorox Company has a one year low of $114.68 and a one year high of $170.43. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.53 and a current ratio of 0.90. The stock has a market cap of $17.58 billion, a PE ratio of 73.44, a PEG ratio of 2.13 and a beta of 0.44.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating analysts' consensus estimates of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The company had revenue of $1.81 billion for the quarter, compared to analysts' expectations of $1.87 billion. During the same period last year, the firm posted $1.51 EPS. Clorox's revenue for the quarter was down 5.3% compared to the same quarter last year. As a group, equities research analysts anticipate that The Clorox Company will post 5.83 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be given a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a yield of 3.39%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox's payout ratio is presently 248.70%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on CLX shares. Morgan Stanley reiterated an "equal weight" rating and set a $160.00 price objective on shares of Clorox in a report on Tuesday, March 26th. The Goldman Sachs Group assumed coverage on Clorox in a research report on Friday, March 1st. They set a "sell" rating and a $140.00 target price on the stock. Citigroup lowered their price objective on shares of Clorox from $155.00 to $150.00 and set a "neutral" rating on the stock in a report on Wednesday, May 1st. Barclays reduced their price objective on shares of Clorox from $136.00 to $132.00 and set an "underweight" rating for the company in a report on Thursday, May 2nd. Finally, Evercore ISI lowered their price objective on Clorox from $145.00 to $142.00 and set an "underperform" rating for the company in a research note on Wednesday, May 1st. Four investment analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $146.43.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.